Orkambi 100 mg lumacaftor / 125 mg ivacaftor

Orkambi 100 mg lumacaftor / 125 mg ivacaftor is a medicine authorised by Swissmedic under authorisation number 67395. The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 December 2019 and the authorisation is valid without a time limit. ATC code R07AX30 places the medicine in the group Other respiratory system products.

  • Dispensing category A
  • Authorisation number 67395
  • ATC R07AX30
  • Synthetic medicines
Authorisation data
Authorisation number67395
NameOrkambi 100 mg lumacaftor / 125 mg ivacaftor
Full nameOrkambi 100 mg lumacaftor / 125 mg ivacaftor, Granulat
Authorisation holderVertex Pharmaceuticals (CH) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeR07AX30
First authorisation23 December 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Orkambi 100 mg lumacaftor / 125 mg ivacaftor, GranulatA23 December 2019
2Orkambi 150 mg lumacaftor / 188 mg ivacaftor, GranulatA23 December 2019
3Orkambi 75 mg lumacaftor / 94 mg ivacaftor, GranulatA31 July 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156 (4 x 14)BeutelR07AX3003.99.0.A
256 (4 x 14)BeutelR07AX3003.99.0.A
356 (4 x 14)BeutelR07AX3003.99.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Orkambi 100 mg lumacaftor / 125 mg ivacaftor authorised in Switzerland?

Yes. Orkambi 100 mg lumacaftor / 125 mg ivacaftor is authorised by Swissmedic under authorisation number 67395, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Orkambi 100 mg lumacaftor / 125 mg ivacaftor have?

Orkambi 100 mg lumacaftor / 125 mg ivacaftor is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Orkambi 100 mg lumacaftor / 125 mg ivacaftor?

The authorisation holder is Vertex Pharmaceuticals (CH) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com